Marcel Špulák

1.1k total citations
34 papers, 931 citations indexed

About

Marcel Špulák is a scholar working on Organic Chemistry, Catalysis and Pharmacology. According to data from OpenAlex, Marcel Špulák has authored 34 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Organic Chemistry, 11 papers in Catalysis and 4 papers in Pharmacology. Recurrent topics in Marcel Špulák's work include Ionic liquids properties and applications (11 papers), Synthetic Organic Chemistry Methods (8 papers) and Quinazolinone synthesis and applications (6 papers). Marcel Špulák is often cited by papers focused on Ionic liquids properties and applications (11 papers), Synthetic Organic Chemistry Methods (8 papers) and Quinazolinone synthesis and applications (6 papers). Marcel Špulák collaborates with scholars based in Czechia, Ireland and Estonia. Marcel Špulák's co-authors include Nicholas Gathergood, Milan Pour, Jiřı́ Kuneš, M. Teresa García, Klaus Kümmerer, Vladimı́r Buchta, Yevgen Karpichev, Andrew Jordan, Stephen J. Connon and Mukund Ghavre and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Green Chemistry.

In The Last Decade

Marcel Špulák

33 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Špulák Czechia 19 530 343 134 99 80 34 931
Ewa Janus Poland 17 298 0.6× 342 1.0× 117 0.9× 30 0.3× 30 0.4× 63 831
Ilona Mirska Poland 7 404 0.8× 733 2.1× 137 1.0× 168 1.7× 28 0.3× 11 1.0k
Larysa Metelytsia Ukraine 14 266 0.5× 177 0.5× 130 1.0× 76 0.8× 21 0.3× 53 584
Joanna Feder‐Kubis Poland 21 478 0.9× 761 2.2× 236 1.8× 137 1.4× 28 0.3× 58 1.5k
Tânia Santos de Almeida Portugal 17 208 0.4× 226 0.7× 144 1.1× 27 0.3× 33 0.4× 37 888
A. Cieniecka–Roslonkiewicz Poland 10 158 0.3× 266 0.8× 63 0.5× 58 0.6× 29 0.4× 15 459
Zhongni Wang China 17 556 1.0× 147 0.4× 146 1.1× 28 0.3× 19 0.2× 95 1.0k
Monika Karpińska Poland 23 391 0.7× 694 2.0× 117 0.9× 16 0.2× 60 0.8× 77 1.2k
Tian Yao China 20 196 0.4× 279 0.8× 155 1.2× 22 0.2× 33 0.4× 66 1.1k
Nazira Karodia United Kingdom 18 609 1.1× 147 0.4× 295 2.2× 22 0.2× 37 0.5× 40 1.0k

Countries citing papers authored by Marcel Špulák

Since Specialization
Citations

This map shows the geographic impact of Marcel Špulák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Špulák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Špulák more than expected).

Fields of papers citing papers by Marcel Špulák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Špulák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Špulák. The network helps show where Marcel Špulák may publish in the future.

Co-authorship network of co-authors of Marcel Špulák

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Špulák. A scholar is included among the top collaborators of Marcel Špulák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Špulák. Marcel Špulák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Капитанов, И. В., Marcel Špulák, Milan Pour, et al.. (2023). Sustainable ionic liquids-based molecular platforms for designing acetylcholinesterase reactivators. Chemico-Biological Interactions. 385. 110735–110735.
2.
Капитанов, И. В., et al.. (2023). Design of sustainable ionic liquids based on l-phenylalanine and l-alanine dipeptides: Synthesis, toxicity and biodegradation studies. Journal of Molecular Liquids. 374. 121285–121285. 13 indexed citations
3.
Dušek, Ján, Jana Maixnerová, Albert Braeuning, et al.. (2023). 2-Substituted quinazolines: Partial agonistic and antagonistic ligands of the constitutive androstane receptor (CAR). European Journal of Medicinal Chemistry. 259. 115631–115631. 6 indexed citations
4.
Maříková, Jana, Jan Korábečný, Daniela Hulcová, et al.. (2021). Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study. Bioorganic & Medicinal Chemistry Letters. 51. 128374–128374. 4 indexed citations
5.
Капитанов, И. В., Andrew Jordan, Yevgen Karpichev, et al.. (2019). Synthesis, self-assembly, bacterial and fungal toxicity, and preliminary biodegradation studies of a series ofl-phenylalanine-derived surface-active ionic liquids. Green Chemistry. 21(7). 1777–1794. 62 indexed citations
6.
Špulák, Marcel, Mukund Ghavre, & Milan Pour. (2016). Recent advances in the transition-metal catalyzed synthesis of multisubstituted pentenolides and related pyranones. Tetrahedron Letters. 58(4). 263–270. 9 indexed citations
7.
Špulák, Marcel, Jana Pourová, Marie Vopršalová, et al.. (2014). Novel bronchodilatory quinazolines and quinoxalines: Synthesis and biological evaluation. European Journal of Medicinal Chemistry. 74. 65–72. 15 indexed citations
8.
Stuchlíková, Lucie Raisová, et al.. (2013). Efficacy of monepantel against lower developmental stages of a multi-resistant and susceptible Haemonchus contortus isolates: an in vitro study. Helminthologia. 50(2). 91–95. 5 indexed citations
9.
Courty, Matthieu, Sylvain Gatard, Marcel Špulák, et al.. (2013). Biomass derived ionic liquids: synthesis from natural organic acids, characterization, toxicity, biodegradation and use as solvents for catalytic hydrogenation processes. Tetrahedron. 69(30). 6150–6161. 78 indexed citations
10.
11.
Stuchlíková, Lucie Raisová, Robert Jirásko, Ivan Vokřál, et al.. (2012). Investigation of the metabolism of monepantel in ovine hepatocytes by UHPLC/MS/MS. Analytical and Bioanalytical Chemistry. 405(5). 1705–1712. 23 indexed citations
12.
Špulák, Marcel, Zdeněk Novák, Karel Palát, et al.. (2012). The unambiguous synthesis and NMR assignment of 4-alkoxy and 3-alkylquinazolines. Tetrahedron. 69(6). 1705–1711. 21 indexed citations
13.
Špulák, Marcel, et al.. (2011). Synthesis and biological activity of desmethoxy analogues of coruscanone A. Bioorganic & Medicinal Chemistry Letters. 21(20). 6062–6066. 9 indexed citations
14.
Pavlik, Ján, Vladimı́r Buchta, Bohuslav Melichar, et al.. (2010). 3,5-Disubstituted pyranone analogues of highly antifungally active furanones: Conversion of biological effect from antifungal to cytostatic. Bioorganic & Medicinal Chemistry Letters. 20(24). 7358–7360. 24 indexed citations
15.
Šenel, Petr, Ivan Votruba, Vladimı́r Buchta, et al.. (2010). Antifungal 3,5-disubstituted furanones: From 5-acyloxymethyl to 5-alkylidene derivatives. Bioorganic & Medicinal Chemistry. 18(5). 1988–2000. 23 indexed citations
16.
Špulák, Marcel, et al.. (2009). Direct C−H Arylation and Alkenylation of 1-Substituted Tetrazoles: Phosphine As Stabilizing Factor. The Journal of Organic Chemistry. 75(1). 241–244. 35 indexed citations
17.
18.
Pour, Milan, et al.. (2001). 3-Phenyl-5-acyloxymethyl-2H,5H-furan-2-ones:  Synthesis and Biological Activity of a Novel Group of Potential Antifungal Drugs. Journal of Medicinal Chemistry. 44(17). 2701–2706. 64 indexed citations
19.
Pour, Milan, Marcel Špulák, Vojtěch Balšánek, et al.. (2000). 3-Phenyl-5-methyl-2H,5H-furan-2-ones: tuning antifungal activity by varying substituents on the phenyl ring. Bioorganic & Medicinal Chemistry Letters. 10(16). 1893–1895. 36 indexed citations
20.
Kuneš, Jiřı́, Marcel Špulák, Karel Waisser, M Slosárek, & Jan Janota. (2000). Quinoxaline derivatives as potential antituberculotic agents.. PubMed. 55(11). 858–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ewa Janus Breakdown of academic impact, for papers by Ilona Mirska Breakdown of academic impact, for papers by Larysa Metelytsia Breakdown of academic impact, for papers by Joanna Feder‐Kubis Breakdown of academic impact, for papers by Tânia Santos de Almeida Breakdown of academic impact, for papers by A. Cieniecka–Roslonkiewicz Breakdown of academic impact, for papers by Zhongni Wang Breakdown of academic impact, for papers by Monika Karpińska Breakdown of academic impact, for papers by Tian Yao Breakdown of academic impact, for papers by Nazira Karodia
Rankless by CCL
2026